RNA-targeting CRISPR enzyme was harnessed as a highly sensitive detector - able to indicate the presence of as little as a single molecule of a target RNA or DNA molecule.
Researchers, including those from Massachusetts Institute of Technology (MIT) and Harvard University in the US, dubbed the new tool SHERLOCK (Specific High-sensitivity Enzymatic Reporter unLOCKing).
This technology could one day be used to respond to viral and bacterial outbreaks, monitor antibiotic resistance, and detect cancer, researchers said.
They detected the presence of Zika virus in patient blood or urine samples within hours.
They also were able to distinguish between the genetic sequences of African and American strains of Zika virus and discriminating specific types of bacteria, such as E coli.
Researchers used the method to detect antibiotic resistance genes and identifying cancerous mutations in simulated cell-free DNA fragments.
Because the tool can be designed for use as a paper-based test that does not require refrigeration, the researchers said it is well suited for fast deployment and widespread use inside and outside of traditional settings - such as at a field hospital during an outbreak, or a rural clinic with limited access to advanced equipment.
This tool offers the sensitivity that could detect an extremely small amount of cancer DNA in a patient's blood sample, for example, which would help researchers understand how cancer mutates over time.
"For public health, it could help researchers monitor the frequency of antibiotic-resistant bacteria in a population. The scientific possibilities get very exciting very quickly," said Collins.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Access to Exclusive Premium Stories
Over 30 subscriber-only stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app